aspirin and extended-release dipyridamole (65162-596)

Drug Facts

Product Profile

Brand Name aspirin and extended-release dipyridamole

Generic Name aspirin and extended-release dipyridamole

Labeler amneal pharmaceuticals llc

Dosage Form CAPSULE

Routes

ORAL

Active Ingredients

aspirin 25 mg/1, dipyridamole 200 mg/1

Manufacturer

Amneal Pharmaceuticals LLC

Identifiers & Regulatory

Product NDC 65162-596

Product ID 65162-596_bf81f508-2def-4916-a2f1-0f73f473be3f

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA206392

Listing Expiration 2026-12-31

Marketing Start 2016-03-28

Pharmacologic Class

Established (EPC)

nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]

Mechanism of Action

cyclooxygenase inhibitors [moa]

Chemical Structure

anti-inflammatory agents, non-steroidal [cs]

Physiologic Effect

decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 65162596

Hyphenated Format 65162-596

Supplemental Identifiers

RxCUI

259081

UPC

0365162596069

UNII

R16CO5Y76E 64ALC7F90C

NUI

N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aspirin and extended-release dipyridamole (source: ndc)

Generic Name aspirin and extended-release dipyridamole (source: ndc)

Application Number ANDA206392 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

25 mg/1
200 mg/1

source: ndc

Packaging

60 CAPSULE in 1 BOTTLE (65162-596-06)

source: ndc

Packages (1)

65162-596-06 60 CAPSULE in 1 BOTTLE (65162-596-06)

Ingredients (2)

aspirin (25 mg/1) dipyridamole (200 mg/1)

Linked Drug Pages (1)

Aspirin and Extended-Release Dipyridamole ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "bf81f508-2def-4916-a2f1-0f73f473be3f", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0365162596069"], "unii": ["R16CO5Y76E", "64ALC7F90C"], "rxcui": ["259081"], "spl_set_id": ["369cb8a3-e1e4-4150-859d-4f788436ddca"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (65162-596-06)", "package_ndc": "65162-596-06", "marketing_start_date": "20160328"}], "brand_name": "Aspirin and Extended-Release Dipyridamole", "product_id": "65162-596_bf81f508-2def-4916-a2f1-0f73f473be3f", "dosage_form": "CAPSULE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "65162-596", "generic_name": "Aspirin and Extended-Release Dipyridamole", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Aspirin and Extended-Release Dipyridamole", "active_ingredients": [{"name": "ASPIRIN", "strength": "25 mg/1"}, {"name": "DIPYRIDAMOLE", "strength": "200 mg/1"}], "application_number": "ANDA206392", "marketing_category": "ANDA", "marketing_start_date": "20160328", "listing_expiration_date": "20261231"}